125 related articles for article (PubMed ID: 8769896)
1. Passage of a delta-opioid receptor selective enkephalin, [D-penicillamine2,5] enkephalin, across the blood-brain and the blood-cerebrospinal fluid barriers.
Williams SA; Abbruscato TJ; Hruby VJ; Davis TP
J Neurochem; 1996 Mar; 66(3):1289-99. PubMed ID: 8769896
[TBL] [Abstract][Full Text] [Related]
2. Transport of the delta-opioid receptor agonist [D-penicillamine2,5] enkephalin across the blood-brain barrier involves transcytosis1.
Egleton RD; Davis TP
J Pharm Sci; 1999 Apr; 88(4):392-7. PubMed ID: 10187748
[TBL] [Abstract][Full Text] [Related]
3. The entry of [D-penicillamine2,5]enkephalin into the central nervous system: saturation kinetics and specificity.
Thomas SA; Abbruscato TJ; Hruby VJ; Davis TP
J Pharmacol Exp Ther; 1997 Mar; 280(3):1235-40. PubMed ID: 9067309
[TBL] [Abstract][Full Text] [Related]
4. Assessment of stereoselectivity of trimethylphenylalanine analogues of delta-opioid [D-Pen(2),D-Pen(5)]-enkephalin.
Witt KA; Slate CA; Egleton RD; Huber JD; Yamamura HI; Hruby VJ; Davis TP
J Neurochem; 2000 Jul; 75(1):424-35. PubMed ID: 10854288
[TBL] [Abstract][Full Text] [Related]
5. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
[TBL] [Abstract][Full Text] [Related]
6. delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites.
Sofuoglu M; Portoghese PS; Takemori AE
Eur J Pharmacol; 1992 Jun; 216(2):273-7. PubMed ID: 1327813
[TBL] [Abstract][Full Text] [Related]
7. Effects of multiple intracerebroventricular injections of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin II on tolerance to their analgesic action and on brain delta-opioid receptors.
Zhao GM; Bhargava HN
Brain Res; 1997 Jan; 745(1-2):243-7. PubMed ID: 9037415
[TBL] [Abstract][Full Text] [Related]
8. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides.
Kiritsy-Roy JA; Marson L; Van Loon GR
J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain disposition and antinociceptive effects of -D-penicillamine2,5-enkephalin in the mouse.
Chen C; Pollack GM
J Pharmacol Exp Ther; 1997 Dec; 283(3):1151-9. PubMed ID: 9399988
[TBL] [Abstract][Full Text] [Related]
11. Stress-induced tolerance to delta receptor agonist DPDPE and selectivity of the irreversible delta-ligand, DALCE.
Calcagnetti DJ; Bowen WD; Holtzman SG
Brain Res; 1990 Feb; 509(2):205-12. PubMed ID: 2157520
[TBL] [Abstract][Full Text] [Related]
12. Determination of delta-opioid in NG108-15 cells.
Ho BY; Holmes BB; Zhao J; Fujimoto J
Eur J Pharmacol; 1997 Jan; 319(1):109-14. PubMed ID: 9030905
[TBL] [Abstract][Full Text] [Related]
13. Insulin enhancement of opioid peptide transport across the blood-brain barrier and assessment of analgesic effect.
Witt KA; Huber JD; Egleton RD; Davis TP
J Pharmacol Exp Ther; 2000 Dec; 295(3):972-8. PubMed ID: 11082431
[TBL] [Abstract][Full Text] [Related]
14. Autoradiographic evidence for decrease in binding of mu- and delta-opioid receptors after subchronic [D-Ala2,D-Leu5]enkephalin treatment in rats.
Tao PL; Seybold VS; Loh HH
Eur J Pharmacol; 1993 Feb; 231(2):145-9. PubMed ID: 8384111
[TBL] [Abstract][Full Text] [Related]
15. Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.
Tao PL; Tsai CL; Chang LR; Loh HH
Eur J Pharmacol; 1991 Aug; 201(2-3):209-14. PubMed ID: 1665782
[TBL] [Abstract][Full Text] [Related]
16. Binding of 3H-D-Pen2-D-Pen5-enkephalin to brain regions and spinal cord membranes of spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Bhargava HN; Rahmani NH
Pharmacology; 1993; 46(2):75-81. PubMed ID: 8382821
[TBL] [Abstract][Full Text] [Related]
17. The effect of naltrindole on spinal and supraspinal delta opioid receptors and analgesia.
Shah S; Davis T; Yoburn BC
Life Sci; 1994; 55(19):1451-8. PubMed ID: 7968211
[TBL] [Abstract][Full Text] [Related]
18. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
[TBL] [Abstract][Full Text] [Related]
19. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
Bowen WD; Kelemen M; Huey R; Stewart D
NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
[TBL] [Abstract][Full Text] [Related]
20. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
